REGISTERED
on 23 Jul 2019
Last Applicant/ Owned by
Lochhamer Str. 11
Planegg-Martinsried
DE
82152
Serial Number
88245830 filed on 31st Dec 2018
Registration Number
5812401 registered on 23rd Jul 2019
Filing Basis
1. intent to use
Disclaimer
NO DATA
RHUDEX
Biotechnology services, namely, the development of T-cell receptor pharmaceutical products and technologies for the treatment of cancer, rheumatoid arthritis, inflammatory and auto-immune diseases; scientific and medical research and development of new technology for others in the field of biotechnology and genomics, pharmaceutical drug development services, and pharmaceutical product development; Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Biotechnology services, namely, the development of T-cell receptor pharmaceutical products and technologies for the treatment of cancer, rheumatoid arthritis, inflammatory and auto-immune diseases; scientific and medical research and development of new technology for others in the field of biotechnology and genomics, pharmaceutical drug development services, and pharmaceutical product development; genetic engineering services, licensing intellectual property, namely, trademarks and patents in the field of biotechnology
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [010]
Medical Instrument Products
Apparatus and instruments for diagnostic and therapeutic research, namely, instruments for measuring tissue damage or movement in limbs or organs; display apparatus, namely, multi-well plates and arrays for medical or clinical diagnosis and analysis; surgical and medical apparatus and instruments, namely, injectors and syringes
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Antibodies, proteins, T cell proteins and peptides for medical use, monoclonal antibodies for clinical or medical use, pharmaceutical and biochemical substances and preparations, namely, small molecules, and CD8O antagonists for the treatment of cancer, rheumatoid arthritis and auto-immune diseases; in vivo immunotherapeutic, immunoprophylactic and immunodiagnostic agents, preparations and substances for clinical or medical use; vaccines; protein conjugates; diagnostic and analytical preparations for medical and veterinary use, namely, products to diagnose and analyze tissue damage caused by inflammation due to auto-immune diseases; enzymes and enzyme preparations for clinical or medical use and the treatment of cancer, rheumatoid arthritis and auto-immune diseases; chemical products for use in medical science, namely, T-cell receptors, small molecule and protein therapeutics; pre-filled vials containing pharmaceuticals and bioceuticals, namely, small molecules and protein therapeutics involving T-cell receptors for the treatment of cancer, rheumatoid arthritis and auto-immune diseases
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 88245830
Mark Type
No Service Mark
Attorney Docket Number
No 52318.3
44D Filed
No
44D Current
No
44E filed
Yes
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 23rd Jul 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 23rd Jul 2019 | REGISTERED-PRINCIPAL REGISTER |
| 07th May 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 07th May 2019 | PUBLISHED FOR OPPOSITION |
| 17th Apr 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 25th Mar 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 25th Mar 2019 | EXAMINER'S AMENDMENT ENTERED |
| 22nd Mar 2019 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 22nd Mar 2019 | EXAMINERS AMENDMENT E-MAILED |
| 22nd Mar 2019 | EXAMINERS AMENDMENT -WRITTEN |